Costs of care at a Diabetic Care Center in Pinar del Río
Keywords:
HEALTH CARE COSTS, COSTS AND COST ANALYSIS/economics, DIABETES MELLITUS, HEALTH CENTERS.Abstract
Introduction: diabetes mellitus has become a serious health problem, due to its high prevalence, in addition to the high degree of mortality and disability it generates.
Objective: to evaluate the economic burden of diabetes mellitus in the Diabetic Care Center of Pinar del Río, during 2016.
Method: cross-sectional descriptive study through the cost approach of the disease, working with a target group of (U = 8623), where all patients attending the aforementioned institution were included, the cost reports for diabetes mellitus issued by the unit were also used, the descriptive statistics was applied.
Results: the direct and indirect costs of diabetes mellitus in the Diabetic Care Center of Pinar del Río in 2016 were not individually reflected, which made us to infer that the general assessment of the economic burden of diabetes mellitus could lead to the non-implementation of the approved budget for 2016 in the Diabetic Care Center.
Conclusions: based on the results of this investigation, it is necessary to reflect on the economic need to separate the costs of diabetes mellitus type 1 and 2 in the analysis of the budget, taking into account that they do not have the same levels of expenses in their treatment, as well as direct and indirect costs, to obtain real costs in the care of patients with the disease.
Downloads
References
1. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al, UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. The Lancet [Internet]. 2011 June[cited 2017 nov 25]; 378(9789): 449-55. Avalaible: https://www.ncbi.nlm.nih.gov/pubmed/21665266.
2. Federación Internacional de Diabetes, Atlas de la Diabetes. 6.ª ed. Bruselas: Federación Internacional de Diabetes; 2014. Disponible en: http://www.fundaciondiabetes.org/upload/publicaciones_ficheros/61/www_25610_Diabetes_Atlas_6th_Ed_SP_int_ok_0914.pdf.
3. World Economic Forum. The Global Risks Report 2016. 11.ª ed. Geneva: Available: http://www3.weforum.org/docs/GRR/WEF_GRR16.pdf.
4. World Health Assembly. Global strategy on Diet, Physical Activity and Health. World Health Organization. Geneva: 2004. Available: http://www.who.int/dietphysicalactivity/strategy/eb11344/strategy_english_web.pdf.
5. Rodríguez Bolaños RA, Reynales Shigematsu LM, Jiménez Ruíz JA, Juárez Márquez SA, Hernández Ávila M. Costos directos de atención médica en pacientes con diabetes mellitus tipo 2 en México: análisis de micro costeo. Rev Panam Salud Pública [Internet]. 2010[citado 5 de mayo 2017]; 28 (6): [aprox.4p.]. Disponible en: http://www.scielosp.org/pdf/rpsp/v28n6/v28n6a02.pdf.
6. American Diabetes Association (ADA). Standards of Medical Care in Diabetes 2013.Diabetes Care [Internet]. 2013 jan [citado 2017 Mayo 21]; 36(1): 11-66. Disponible en: http://care.diabetesjournals.org/content/36/Supplement_1/S11.full.pdf+html.
7. Aslan I y Ustun O. Decision analysis and markov chains for management of chronic kidney failures in turkey. ISS & MLB [Internet] 2013 sep 24-26; Japón, Nagoya. Disponible en: https://www.researchgate.net/profile/Imran_Aslan/publication/269275309_DECISION_ANALYSIS_AND_MARKOV_CHAINS_FOR_MANAGEMENT_OF_CHRONIC_KIDNEY_FAILURES_IN_TURKEY/links/54858cab0cf2437065c9e200/DECISION-ANALYSIS-AND-MARKOV-CHAINS-FOR-MANAGEMENT-OF-CHRONIC-KIDNEY-FAILURES-IN-TURKEY.pdf
8. Rpari NV, Elorza MA, Mascosa NS. Costos de enfermedades: clasificación y perspectivas de análisis. Rev. Cienc. Salud. [Internet] 2016; 15(1):49-58 [Citado 5 de mayo 2017]. Disponible en: http://www.scielo.org.co/pdf/recis/v15n1/v15n1a05.pdf.
9. Villacrés N. Análisis del financiamiento de la atención a enfermedades crónicas no transmisibles. Rev Fac Cien Med [Internet]. 2016 [citado 2017 Sep 19]; 41 (1):185-194. Disponible en: http://www.google.com.cu/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&ved=0ahUKEwjjxfeL9ZjYAhWLQ98KHbDNAOsQFggsMAE&url=http%3A%2F%2Frevistadigital.uce.edu.ec%2Findex.php%2FCIENCIAS_MEDICAS%2Farticle%2Fdownload%2F317%2FPDF&usg=AOvVaw182fRC0K88Yi3ShOlLHvIQ.
10. Legetic B, Medici A, Hernández Ávila M, Alleyne G, Hennis A. Las dimensiones económicas de las enfermedades no transmisibles en América Latina y el Caribe. Organización Panamericana de la Salud. Washington: DCP3; 2017 [citado 5 de mayo 2017]. Disponible en: http://iris.paho.org/xmlui/bitstream/handle/123456789/33994/9789275319055-spa.pdf?sequence=1
11. International Diabetes Federation. DIABETES ATLAS. 8th. Edition [Internet]. 2017 [citado 5 de mayo 2017]. Disponible en: http://diabetesatlas.org/resources/2017-atlas.html.
12. Bueno Campos E. Cruz Roche I. Durán Herrera JJ. Economía de la empresa. Análisis de las decisiones empresariales. Ed. Pirámide ; 2013.
13. Hart W, Collazo Herrera M. Costos del diagnóstico y tratamiento de la diabetes mellitus en diferentes países del mundo. Rev Cubana Endocrinol [internet]. 1998 [citado 2017 Sep 19]; 9(3): [aprox. 8p.]. Disponible en: http://bvs.sld.cu/revistas/end/vol9_3_98/end05398.htm
14. Oliva Moreno J. La valoración de costes indirectos en economía de la salud. Fundamentos de análisis económico I. 2008. [citado 2017 Sep 19]. Disponible en: http://eprints.ucm.es/6688/1/9917.pdf.
15. Más López CJ. Los gastos indirectos asociados a las enfermedades: qué enfoque utilizar. Cofin Habana [Internet]. 2016 ene [citado 2017 Sep 19]; 10 (1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S207360612016000100009.
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
